State Street SPDR S&P Biotech ETF (XBI) 주가, 시세, 뉴스 및 이력

XBIARCA

Trade with Public

$155.03

-1.02-0.65%

가까이에: Sep 25, 5:00 PM EST

개요뉴스 Holdings 배당금 매도 수량

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

11.03B

Fund Score

주요 통계

개장가

$156.80

고가

$157.17

52주 최고가

$169.89

운용자산

11.03B

배당

$0.58

배당락일

6월 22, 2026

거래량

8.24M

시가 총액

$18.79B

관리 수수료

0.35%

P/E 비율

17.14

전일 종가

$156.05

저가

$153.85

52주 최저가

$95.74

발행 주식

75.22M

수익률

0.37%

배당금 지급시기

평균 일일 볼륨

8.74M

베타

0.84

평균 비용 비율

0.35%

P/B 비율

4.90

SPDR Series Trust - SPDR S&P Biotech ETF의 최근 뉴스

Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach

B. Riley sees 40+ biotech catalysts ahead as rising rates pressure XBI, setting up a key test for the sector during the Q3 2026 earnings season.

Chandrima Sanyal

Economy Grows 63% in Six Years, 30-Year Treasury Lost Almost As Much

Over six years, U.S. nominal GDP rose 63% while the 30-year Treasury fell 60%. Are investors positioned for a surge in stocks and yields?

Piero Cingari

Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets

Cathie Wood’s ARKG bought Ionis, Beam, Veracyte and Scribe Therapeutics. Here are the biotech ETFs that also hold her latest bets.

Chandrima Sanyal

Healthcare ETFs Were Left Behind. JPMorgan Sees the Money Coming Back

JPMorgan sees healthcare ETF flows reversing, with Eli Lilly and AbbVie among stocks that could benefit from renewed sector rotation.

Chandrima Sanyal

What's Going On With Novavax Stock?

Shares of Novavax are trading higher Tuesday. The stock is up over 30% over the trailing month as traders weigh updated autumn vaccine authorizations against the company's broader strategic pivot toward licensing and cost-structure optimization.

Henry Khederian

FAQ

State Street SPDR S&P Biotech ETF (XBI) 주식을 어떻게 사나요?

당신은 어떤 온라인 중개업체를 통해 ARCA:XBI 주식을 구매할 수 있습니다.

우리의 최고의 주식 중개업체 목록을 확인하세요.

State Street SPDR S&P Biotech ETF (XBI)의 경쟁자는 누구인가요?

State Street SPDR S&P Biotech ETF에 대한 경쟁사가 없습니다.

State Street SPDR S&P Biotech ETF (XBI) 주식의 예측 또는 목표 가격은 무엇입니까?

합의된 목표 가격을 제공하기 위한 State Street SPDR S&P Biotech ETF에 대한 분석은 없습니다.

현재 State Street SPDR S&P Biotech ETF (XBI) 주가가 얼마인가요?

State Street SPDR S&P Biotech ETF (ARCA: XBI)의 주식 가격은 마지막으로 에 업데이트된 $입니다.

State Street SPDR S&P Biotech ETF (XBI)는 배당금을 지급하나요?

State Street SPDR S&P Biotech ETF에는 예정된 배당이 없습니다.

State Street SPDR S&P Biotech ETF (ARCA:XBI)의 실적 발표는 언제인가요?

State Street SPDR S&P Biotech ETF에 대한 예정된 다가오는 실적이 없습니다.

State Street SPDR S&P Biotech ETF (XBI)는 분할될 예정인가요?

State Street SPDR S&P Biotech ETF에는 예정된 분할이 없습니다.

주요 통계

개장가

$156.80

고가

$157.17

52주 최고가

$169.89

운용자산

11.03B

배당

$0.58

배당락일

6월 22, 2026

거래량

8.24M

시가 총액

$18.79B

관리 수수료

0.35%

P/E 비율

17.14

전일 종가

$156.05

저가

$153.85

52주 최저가

$95.74

발행 주식

75.22M

수익률

0.37%

배당금 지급시기

평균 일일 볼륨

8.74M

베타

0.84

평균 비용 비율

0.35%

P/B 비율

4.90

개요

섹터

N/A

산업

N/A

ETF Details

Sector	Healthcare
Category	Mid Performer-Mid Growth
Investment Style	Small Cap Blend
Fund Inception	1월 31, 2006
Managers	Raymond Donofrio Karl A. Schneider
Definition	Most of the stocks in this equity fund have average financial performance and average growth potential

Investment Policy

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).

Top ETF Holdings

Symbol	Name	Share %
TWST	Twist Bioscience Corp.	1.82%
KYMR	Kymera Therapeutics In...	1.43%
RVMD	Revolution Medicines I...	1.37%
ORKA	Oruka Therapeutics Inc...	1.40%
MRNA	Moderna Inc	3.04%
HALO	Halozyme Therapeutics ...	1.48%
NTRA	Natera Inc	1.48%
BM	Roivant Sciences Ltd. ...	1.39%
TVTX	Travere Therapeutics I...	1.37%
INSM	Insmed Inc	1.37%